000283132 001__ 283132
000283132 005__ 20240918102249.0
000283132 0247_ $$2doi$$a10.3892/or.2023.8626
000283132 0247_ $$2ISSN$$a1021-335X
000283132 0247_ $$2ISSN$$a1791-2431
000283132 037__ $$aDKFZ-2023-01919
000283132 082__ $$a610
000283132 1001_ $$0P:(DE-He78)bf58bfc5eb550025e7f1f64520b68feb$$aBauer, Nathalie$$b0$$eFirst author
000283132 245__ $$a[Corrigendum] Establishment of hypoxia induction in an in vivo animal replacement model for experimental evaluation of pancreatic cancer
000283132 260__ $$aAthens$$bSpandidos Publ.$$c2023
000283132 3367_ $$2DRIVER$$aarticle
000283132 3367_ $$2DataCite$$aOutput Types/Journal article
000283132 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1726647749_8429$$xErratum/Correction
000283132 3367_ $$2BibTeX$$aARTICLE
000283132 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000283132 3367_ $$00$$2EndNote$$aJournal Article
000283132 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000283132 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000283132 7001_ $$0P:(DE-He78)0144e4bf6eab6053de5a445069012063$$aLiu, Lizhen$$b1
000283132 7001_ $$0P:(DE-HGF)0$$aAleksandrowicz, Ewa$$b2
000283132 7001_ $$0P:(DE-HGF)0$$aHerr, Ingrid$$b3$$eLast author
000283132 773__ $$0PERI:(DE-600)2120548-6$$a10.3892/or.2023.8626$$gVol. 50, no. 4, p. 189$$n4$$p189$$tOncology reports$$v50$$x1021-335X$$y2023
000283132 909CO $$ooai:inrepo02.dkfz.de:283132$$pVDB
000283132 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bf58bfc5eb550025e7f1f64520b68feb$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000283132 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0144e4bf6eab6053de5a445069012063$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000283132 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000283132 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000283132 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000283132 9141_ $$y2023
000283132 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-12
000283132 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-12
000283132 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-12
000283132 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bONCOL REP : 2022$$d2023-10-25
000283132 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-25
000283132 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-25
000283132 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-25
000283132 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-25
000283132 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-25
000283132 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-25
000283132 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-25
000283132 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-25
000283132 9201_ $$0I:(DE-He78)G403-20160331$$kG403$$lMolekulare Onkochirurgie$$x0
000283132 980__ $$ajournal
000283132 980__ $$aVDB
000283132 980__ $$aI:(DE-He78)G403-20160331
000283132 980__ $$aUNRESTRICTED